Osteosarcoma: a review of current and future therapeutic approaches

被引:282
作者
Zhao, Xin [1 ]
Wu, Qirui [2 ]
Gong, Xiuqing [2 ]
Liu, Jinfeng [2 ]
Ma, Yujie [2 ]
机构
[1] Anhui Chest Hosp, 397 Jixi Rd, Hefei 230022, Peoples R China
[2] Shanghai Univ, Mat Genome Inst, Shanghai 201800, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; Staging; Diagnosis; Treatment; LIMB-SALVAGE; GENE-THERAPY; NEOADJUVANT CHEMOTHERAPY; IMMUNOTHERAPY; RADIOTHERAPY; AMPUTATION; DIAGNOSIS; CHILDREN; SURVIVAL; TUMORS;
D O I
10.1186/s12938-021-00860-0
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options.
引用
收藏
页数:14
相关论文
共 110 条
[1]
Update on Survival in Osteosarcoma [J].
Anderson, Megan E. .
ORTHOPEDIC CLINICS OF NORTH AMERICA, 2016, 47 (01) :283-+
[2]
[Anonymous], 2010, J SURG ONCOL, V94, P21
[3]
[Anonymous], 2010, MOD MED IMAGEL
[4]
Common Musculoskeletal Tumors of Childhood and Adolescence [J].
Arndt, Carola A. S. ;
Rose, Peter S. ;
Folpe, Andrew L. ;
Laack, Nadia N. .
MAYO CLINIC PROCEEDINGS, 2012, 87 (05) :475-487
[5]
Evaluation of clinical process in osteosarcoma patients treated with chemotherapy including cisplatin, adriamycin, ifosfamide, and etoposide and determination of the treatment sequels in a long-term 11-year follow-up [J].
Aznab, Mozaffar ;
Hematti, Maryam .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (02) :291-296
[6]
Bajpai J, 2009, J CLIN ONCOL, V27, P10540, DOI [10.1200/jco.2009.27.15_suppl.10540, DOI 10.1200/JCO.2009.27.15_SUPPL.10540]
[7]
Physeal Distraction for Joint Preservation in Malignant Metaphyseal Bone Tumors in Children [J].
Betz, Michael ;
Dumont, Charles E. ;
Fuchs, Bruno ;
Exner, G. Ulrich .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2012, 470 (06) :1749-1754
[8]
Making gene therapy for osteosarcoma a reality [J].
Broadhead, Matthew L. ;
Clark, Jonathan C. M. ;
Choong, Peter F. M. ;
Dass, Crispin R. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (04) :477-480
[9]
Brown Lindsay C., 2014, Sarcoma, V2014, P418270, DOI 10.1155/2014/418270
[10]
18F-FDG PET/CT in a Rare Malignant Extraskeletal Osteosarcoma [J].
Cao, Qi ;
Lu, Minh ;
Huebner, Thomas ;
Dilsizian, Vasken ;
Chen, Wengen .
CLINICAL NUCLEAR MEDICINE, 2013, 38 (09) :E367-E369